Pfizer, AstraZeneca to invest nearly $1 bn in France
Pfizer would invest $538.5 million in France to build up its research and development work in the country, while AstraZeneca…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Pfizer
Pfizer’s Braftovi to command 42 per cent share of BRAF inhibitors melanoma market by 2028:…
GlobalData’s patient-based forecast reveals that the BRAF inhibitor market for melanoma will reach a key milestone by 2028, with…
Glenmark partners with Pfizer to launch Abrocitinib in India
When launched in India, it will be co-marketed under the brand names JABRYUS and CIBINQO by Glenmark and Pfizer respectively
Fortifying Brand India Pharma
Lessons and insights on measures and approaches to drive innovation, quality and growth in India's pharma sector from industry…
USFDA approves SpringWorks Therapeutics’ non-cancerous tumor treatment
Shares of the company were up about 18 per cent after the bell
Penbraya approval sparks shift to pentavalent meningococcal vaccines in US: GlobalData
GSK is also in the process of developing a pentavalent vaccine, and positive Phase III data were announced earlier this year.…
Pfizer to price COVID treatment Paxlovid at $1,390 per course
Paxlovid, the most commonly prescribed at home treatment for COVID19 in the U.S., will remain available for free to patients there…
MHRA approves Pfizer/BioNTech’s adapted COVID-19 vaccine for Omicron XBB.1.5
The vaccine has been approved for use in individuals from six months of age
US FDA approves ABRYSVO, Pfizer’s maternal RSV vaccine for infants
First and only US approval of a maternal vaccine to help protect infants at birth through six months of life from lower…
Biden administration to urge Americans get COVID-19 boosters
The official said that while the Centers for Disease Control and Prevention are reporting an increase in infections and hospital…